In the 90 days prior to the date of this filing, there have been 34 insider transactions from the activities of 7 individual insiders all of which have been purchases and resulted in the acquisition of 4,220,250 company shares. Relative to the preceding 90-day window of time, there were 18 transactions from 2 insiders which resulted in the net acquisition of 792,232 shares.
This is less than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 35.3 transactions per company, and disposition of 6,980 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119034967/xslF345X03/doc4.xml
|Market Chatter: Tesla's Shanghai Plant Gains Access ...|
|Insider Sale at Cornerstone OnDemand (CSOD) Continue...|
|Foundation Building Materials (FBM) Insider Makes Si...|
|Insider buy at USA Technologies (USAT) Extends the T...|
|Insider Selling at HubSpot (HUBS) Continues with Sig...|